Deletion of CD1d on goblet cells reversed the protective effects of EGFRi treatment on DSS colitis, including colon shortening and histology scores (Fig. i-k), consistent with the protective effect of EGFRi being mediated through CD1d expression by goblet cells and colonic iNKT cell expansion. Here, CD1D is linked to colitis.